The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Minimal residual illness, or MRD, testing might have the potential to supply peace of thoughts to survivors of breast most cancers, as a survivor and...
A section 3 examine discovered including Monjuvi (tafasitamab) and Revlimid (lenalidomide) to straightforward R-CHOP chemotherapy improved progression-free survival for adults with newly...
Suleika Jaouad, the Emmy-winning journalist and creator of “Between Two Kingdoms” and “The Ebook of Alchemy,” obtained her first prognosis of leukemia...
2025: Restoration. Gratitude. Ceremony.2026: Visionary. Constant. Awakening.Wanting again at this 12 months's journey, I discover myself overwhelmed by the duty of selecting...
Lung most cancers analysis and affected person experiences made headlines in 2025, from surgical advances and focused therapies to private tales that...
Dr. Vinayak Venkataraman sat down for an interview with CURE to debate the evolving remedy panorama for gastrointestinal stromal tumors (GIST), with...
